1.6794
20-2月-25 13:03:53
15 分の遅延
株式
+0.0194
+1.17%
本日の幅
1.6100 - 1.6850
ISIN
N/A
ソース
NASDAQ
Neumora Therapeutics Announces Appointment of Robert Lenz, M.D., Ph.D., as Executive Vice President, Head of Research and Development
10 10 2023 07:00:00 提供 Nasdaq GlobeNewswire
Neumora Therapeutics Announces Pricing of Initial Public Offering
14 9 2023 20:49:04 提供 Nasdaq GlobeNewswire